glenmark pharmaceuticals
Glenmark's Favipiravir shows positive results in Phase-3 COVID-19 trial
The results also demonstrated 40 per cent faster achievement of 'clinical cure' defined as the physician's assessment of normalization
India's Glenmark to test potential covid19 drug combination
Glenmark is already conducting clinical trials in India of just favipiravir as a potential treatment for COVID-19
1 of 1